NeOnc Technologies (NTHI) announced the appointment of Dr. Alexandra M. Miller to its scientific advisory board. Dr. Miller is the Chief of the Neuro-oncology Program and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, where she specializes in treating patients with primary brain tumors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTHI:
- NeOnc Technologies appoints Henry Friedman to SAB
- NeOnc Technologies to be featured on ‘Health Uncensored with Dr. Drew’
- NeOnc Technologies Advances to Phase II Brain Cancer Trial
- NeOnc receives FDA authorization to proceed with Phase II trial of NEO212
- NeOnc closes strategic acquisition of advanced AI, 3D bioprinting IP